-+ 0.00%
-+ 0.00%
-+ 0.00%

Galmed Pharmaceuticals Has Received A Notice Of Allowance For A U.S. Patent Titled "TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS"

Benzinga·07/01/2026 19:59:16
Listen to the news